REFERENCES
- Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995.
- Peters DH, Heather AF, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic proper-ties and clinical efficacy. Drugs 1992; 44: 750–99.
- Hoepelman IM, Schneider MME. Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents 1995; 5: 145–67.
- Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1993; 31 (suppl E): 39-50.
- Daniel RR. Comparison of azithromycin and co-amoxi-clay in the treatment of otitis media in children. J Antimicrob Chemother 1993; 31 (suppl E): 65-71.
- Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxidav for the treatment of acute oti-tis media in children. J Antimicrob Chemother 1993; 31 (suppl E): 81-8.
- Principi N, Ambrosioni G, Caramia G, et al. Azithromycin versus amoxicillin/ clavulanate in pediatric acute otitis media: comparative, randomized, open study. In: Neu HC, Young LS, Zinner SH, Acar JF, eds. New Macrolides, Azalides, and Streptogramins in Clinical Practice. New York: Marcel Dekker, Inc, 1995: 422–7.
- Hamill J. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngi-tis and tonsillitis in children. J Antimicrob Chemother 1993; 31 (suppl E): 89-94.
- Weippl G. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. J Antimicrob Chemother 1993; 31 (suppl E): 95-101.
- Principi N, Marchisio P, Biasini G, et al. Azithromycin versus erythromycin in the treatment of paediatric communi-ty-acquired pneumonia. Eur J Clin Res 1993; 4: 127–33.
- Ronnchetti R, Blasi F, Grossi E, Pecori A and The Azithromycin Pediatric Research Group. The role of azithromycin in treating children with community-acquired pneumonia. Curr Ther Res 1994; 55: 965–70.
- Hopkins S. Clinical safety and tolerance of azithromycin in children. J Antimicrob Chemother 1993; 31 (Suppl. E): 111-117.
- Schönwald S, Skerk V, Petricevic I, Car V, Majerus-Misic U, Gunjaca M. Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumo-nia. Eur J Clin Microbiol Infect Dis 1991; 10: 877–880.